Vimarsana
Biggest News Aggregation in the World

Page 4 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction - Vimarsana News

Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction

Study evaluates senolytic CAR T-cell therapy targeting uPAR-positive cells in aged mice, showing its effectiveness in mitigating age-related metabolic dysfunction and offering a potential long-lasting treatment for aging-associated conditions.

Lonza chairman to step down, drugmaker confirms targets, shares soar - Vimarsana News

Lonza chairman to step down, drugmaker confirms targets, shares soar

Lonza said on Friday Chairman Albert Baehny will step down in May after six years in the job, in a second senior management reshuffle in recent months as the Swiss contract drug manufacturer grapples...

Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin - adhoc - Börsennachrichten - Vimarsana News

Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin - adhoc - Börsennachrichten

Lonza Group AG Key word Annual Results Lonza Delivers Solid 2023 Performance with 109% CER Sales Growth and 298% CORE EBITDA Margin 26Jan2024 0650 CETCEST Release of an ad hoc announcement pursuant t

Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin - Vimarsana News

Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin

Lonza Group AG / Key word: Annual Results Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin 26-Jan-2024 / 06:50 CET/CEST Release of an ad hoc...

Lonza chairman to step down, confirms margin target - Vimarsana News

Lonza chairman to step down, confirms margin target

Lonza said on Friday Chairman Albert Baehny will step down in May after six years in the job, in a second senior management reshuffle in recent months as the Swiss contract drug manufacturer grapples...